EDECRIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Edecrin, and what generic alternatives are available?
Edecrin is a drug marketed by Bausch and is included in two NDAs.
The generic ingredient in EDECRIN is ethacrynic acid. There are thirteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ethacrynic acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Edecrin
A generic version of EDECRIN was approved as ethacrynic acid by EDENBRIDGE PHARMS on June 30th, 2016.
Summary for EDECRIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Clinical Trials: | 1 |
Patent Applications: | 4,120 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for EDECRIN |
What excipients (inactive ingredients) are in EDECRIN? | EDECRIN excipients list |
DailyMed Link: | EDECRIN at DailyMed |
Recent Clinical Trials for EDECRIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Kansas Medical Center | Phase 1 |
Eugene Lee, MD | Phase 1 |
Pharmacology for EDECRIN
Drug Class | Loop Diuretic |
Physiological Effect | Increased Diuresis at Loop of Henle |
US Patents and Regulatory Information for EDECRIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | EDECRIN | ethacrynate sodium | INJECTABLE;INJECTION | 016093-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch | EDECRIN | ethacrynic acid | TABLET;ORAL | 016092-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch | EDECRIN | ethacrynic acid | TABLET;ORAL | 016092-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |